Union Budget 2025-26: Customs duty hike likely on key pharma, RE products

Key components in the renewable energy industry such as special bearings, gearboxes, yaw components, wind turbine controllers are currently subjected to a concessional customs duty of 5 per cent

Prices of active pharmaceutical ingredients (APIs) have been declining over the past several months, boosting the margins of drug manufacturers. However, many industry insiders attribute this to a predatory pricing strategy by Chinese companies, and
Representative Picture
Monika Yadav Delhi
2 min read Last Updated : Jan 23 2025 | 11:56 PM IST

Don't want to miss the best from Business Standard?

In the upcoming 2025-26 Budget, sectors such as renewable energy and pharmaceutical may see an increase in basic Customs duty (BCD) rates on a raft of items set to lose their concessional rates after the sunset clause ends on March 31 this year. 
Key components in the renewable energy sector, such as special bearings, gearboxes, yaw components, and wind turbine controllers, currently attract a concessional Customs duty of 5 per cent. Moreover, parts required for the manufacture and maintenance of blades for rotor generators, along with raw materials for producing these blades and their sub-components, are included in this category, all subject to the same 5 per cent duty. 
According to Harisudhan M, partner at PwC, the government has been supporting the industry by offering concessional Customs duty rates of 5 per cent for specific components. 
“Based on industry representations, the government has set a sunset clause for the withdrawal of Customs duty concessions on specified parts and components of wind-operated electricity generators and blades, effective March 31, 2025. Given this scenario, there is a low likelihood of an extension of such concessions. The government aims to promote Make in India for these components to boost their domestic manufacturing,” he added. 
In the pharmaceutical sector, nearly 100 drugs, including glucagon, dopamine, and somatropin, which currently attract a concessional duty of 5 per cent, are also facing the sunset clause on March 31, 2025. Meanwhile, more than 70 life-saving drugs that currently carry zero BCD will see the same clause take effect on March 31, 2025. 
“We hope the government considers granting an extension of the sunset clause for these drugs. Many of these drugs are either exempt from BCD or attract a lower rate, and there could be merit in maintaining this position,” said Suresh Nair, partner at EY. 
In the telecom realm, goods specified for the manufacture of telecom-grade optical fibres and cables, including fibre reinforced plastic rods, enjoy a duty rate of nil. These items also face a sunset date of March 31, 2025. 
“The budget may extend basic customs duty on raw materials for manufacturing of telecom equipment for some more time to stabilise growth of manufacturing in India,” said Kunal Chaudhary, telecom tax leader at EY.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Customs dutyCustomsPharma sectorrenewable

Next Story